Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05132400 · ClinicalTrials.gov registry record
PiPT in ADSM With MSD
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 427
- Enrollment target
NCT05132400: Completed study, sponsored by NYU Langone Health.
NCT05132400 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 427 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05132400 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 427 participants
- Enrollment target
Study Summary
The study objective is to establish feasibility of implementing a psychologically informed rehabilitation strategy while concurrently assessing its' effectiveness in Active duty service members (ADSM) with musculoskeletal disorders (MSD) seeking care in a US Navy shore-based healthcare setting. This intervention is intended to improve the management of chronic pain in order to optimize ADSM function. The study team is proposing an observational prospective comparative cohort study. This study tests an implementation/strategy while observing/gathering information on the clinical intervention and related outcomes.
Primary Outcome
PDI consists of 7 categories of life activity. The participant is asked to circle the number on the scale that describes the level of disability on typically experiences. A score of 0 means no disability at all, and a score of 10 signifies that all of the activities in which one would normally be involved have been totally disrupted or prevented by pain. The total range of score is 0-70; the higher the score, the greater the person's disability due to pain.
Interventions
- BEHAVIORAL Psychological-informed Physical Therapy (PiPT) Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 427 participants |
| Start Date | 2021-12-28 |
| Est. Completion | 2024-06-01 |
What the finished NCT05132400 record still lists
NCT05132400 is an observational study that tracks outcomes without assigning an intervention. The registered 427 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Psychological-informed Physical Therapy (PiPT) Training is the first listed.
NCT05132400 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05132400 about?
NCT05132400 is a clinical study titled "PiPT in ADSM With MSD". The study objective is to establish feasibility of implementing a psychologically informed rehabilitation strategy while concurrently assessing its' effectiveness in Active duty service members (ADSM) with musculoskeletal disorders (MSD) seeking care in a US Navy shore-based healthcare setting. This...
What is the current status of trial NCT05132400?
This trial is currently completed. The enrollment target is 427 participants. The study started on 2021-12-28. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT05132400?
The interventions under investigation include: Psychological-informed Physical Therapy (PiPT) Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05132400?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05566431 · 428 participants · NA
Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics
- NCT05646316 · 428 participants · Phase 3
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
- NCT05797610 · 428 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- NCT06073626 · 428 participants · NA
Addressing Genomic Disparities in Cancer Survivors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI